0000103623-24-000019.txt : 20240130 0000103623-24-000019.hdr.sgml : 20240130 20240130162359 ACCESSION NUMBER: 0000103623-24-000019 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240130 DATE AS OF CHANGE: 20240130 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Viking Therapeutics, Inc. CENTRAL INDEX KEY: 0001607678 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 461073877 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-37355 FILM NUMBER: 24578504 BUSINESS ADDRESS: STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-704-4660 MAIL ADDRESS: STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Lian Brian CENTRAL INDEX KEY: 0001614578 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O SEELOS THERAPEUTICS, INC. STREET 2: 300 PARK AVENUE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 144 1 primary_doc.xml 144 0001614578 XXXXXXXX LIVE 0001607678 Viking Therapeutics, Inc. 001-37355 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660 Lian Brian Officer common Oppenheimer & Co Inc

85 Broad Street New York NY 10004

35000 838250.00 100028953 01/30/2024 NASDAQ Common 01/05/2017 NQ Grant Issuer N 35000 01/05/2017 N/A Y POA on File selling pursuant to 10b5-1 trading plan dated 09/29/2023 01/30/2024 09/29/2023 Brian Lian